BECTON DICKINSON & CO(BDX)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

BECTON DICKINSON & CO (BDX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BDX at 59.0/100 on a 32-signal composite quality model, placing it at rank #957 of 2,961 stocks — the top half of the AI-ranked universe. BDX scores in the top quartile across revenue scale (93.3), earnings quality (92.2). Areas of concern include profitability (35.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), BECTON DICKINSON & CO reports quarterly revenue of $5.0B, net income of $377.0M, an operating margin of 13.3%. Top institutional holders of BDX by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, MASSACHUSETTS FINANCIAL SERVICES, based on the most recent SEC filings. BDX trades on the NYSE exchange and files with the SEC under CIK 10795. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BDX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BECTON DICKINSON & CO directly from SEC EDGAR.

AI Quality Score

59.0/100

AI Rank

#957

Revenue

$5.0B

Net Income

$377.0M

Free Cash Flow

$633.0M

Operating Margin

13.3%

BDX key financials by period

BECTON DICKINSON & CO reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$21.8B$1.7B11.8%
FY 202410-K$20.2B$1.7B11.9%
FY 202310-K$19.4B$1.5B10.9%
FY 202210-K$18.9B$1.8B12.1%
FY 202110-K$19.1B$2.1B11.8%
FY 202010-K$16.1B$874.0M5.7%

Institutions holding BDX

Institutional investors reporting a position in BECTON DICKINSON & CO on SEC Form 13F.
InstitutionSharesValueReported
BlackRock24,592,166$3.7B2026-06-30
VANGUARD CAPITAL MANAGEMENT17,987,834$2.7B2026-06-30
MASSACHUSETTS FINANCIAL SERVICES8,650,967$2.5B2026-06-30
STATE STREET15,000,064$2.3B2026-06-30
VANGUARD PORTFOLIO MANAGEMENT14,974,136$2.3B2026-06-30
First Eagle Investment Management13,815,335$2.1B2026-06-30
Invesco Ltd.8,898,488$1.3B2026-06-30
GEODE CAPITAL MANAGEMENT8,141,586$1.2B2026-06-30
FRANKLIN RESOURCES7,011,592$1.1B2026-06-30
WELLINGTON MANAGEMENT GROUP LLP6,357,986$962.2M2026-06-30
BDX

BECTON DICKINSON & CO

BDX
NYSELarge CapHealthcare

13F Pro Quality Score

59.0/100

Rank #957 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

49.6/100

Profitability

35.7/100

Balance Sheet

51.2/100

Earnings Quality

92.2/100

Free Cash Flow

59.5/100

Institutional Flow

63.6/100

Revenue Scale

93.3/100

Dilution Risk

52.5/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$4.98B

Net Income

Q2 2026
EDGAR

$377.00M

EPS (Diluted)

Q2 2026
EDGAR

$1.37

Operating Margin

Q2 2026
EDGAR

13.3%

ROIC

Q2 2026
EDGAR

6.4%

Free Cash Flow

Q2 2026
EDGAR

$633.00M

Debt/Equity

Q2 2026
EDGAR

0.69

Top Institutional Holders

as of Q2 2026
$41.35B total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…